|
1
|
Klaiber U, Hackert T and Neoptolemos JP:
Adjuvant treatment for pancreatic cancer. Transl Gastroenterol
Hepatol. 4:272019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kong K, Guo M, Liu Y and Zheng J: Progress
in animal models of pancreatic ductal adenocarcinoma. J Cancer.
11:1555–1567. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma YY, Shi JJ, Chen JB, Xu KC and Niu LZ:
Irreversible electroporation for liver metastasis from pancreatic
cancer: A case report. World J Clin Cases. 8:390–397. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perinel J and Adham M: Palliative therapy
in pancreatic cancer-palliative surgery. Transl Gastroenterol
Hepatol. 4:282019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu G, Jiang Z, Qiao M and Wang F:
Lnc-GIHCG promotes cell proliferation and migration in gastric
cancer through miR-1281 adsorption. Mol Genet Genomic Med.
7:e7112019. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fu R, Wang X, Hu Y, Du H, Dong B, Ao S,
Zhang L, Sun Z, Zhang L, Lv G, et al: Solamargine inhibits gastric
cancer progression by regulating the expression of lncNEAT1_2 via
the MAPK signaling pathway. Int J Oncol. 54:1545–1554.
2019.PubMed/NCBI
|
|
8
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: lncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen LS, Hu XF, Chen T, Shen GL and Cheng
D: Integrated network analysis to explore the key mRNAs and lncRNAs
in acute myocardial infarction. Math Biosci Eng. 16:6426–6437.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Liu X, Li H, Pan H, Acharya A, Deng
Y, Yu Y, Haak R, Schmidt J, Schmalz G, et al: Integrated analysis
of long noncoding RNA-associated competing endogenous RNA network
in periodontitis. J Periodontal Res. 53:495–505. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lei Y, Shi Y, Duan J, Liu Y, Lv G, Shi R,
Zhang F, Yang Q and Zhao W: Identification of alternative splicing
and lncRNA genes in pathogenesis of small cell lung cancer based on
their RNA sequencing. Adv Clin Exp Med. 28:1043–1050. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu H, Lu J, Zhao H, Chen Z, Cui Q, Lin Z,
Wang X, Wang J, Dong H, Wang S, et al: Functional long noncoding
RNAs (lncRNAs) in clear cell kidney carcinoma revealed by
reconstruction and comprehensive analysis of the lncRNA-miRNA-mRNA
regulatory network. Med Sci Monit. 24:8250–8263. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hamilton MJ, Girke T and Martinez E:
Global isoform-specific transcript alterations and deregulated
networks in clear cell renal cell carcinoma. Oncotarget.
9:23670–23680. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li D, Jiang X, Zhang X, Cao G, Wang D and
Chen Z: Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell
proliferation, migration, and invasion through upregulating CDCA7
via sponging miR-302e. In Vitro Cell Dev Biol Anim. 55:577–585.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan J, Wei Q, Liao J, Zou Y, Song D, Xiong
D, Ma C, Hu X, Qu X, Chen L, et al: Noncanonical Wnt signaling
plays an important role in modulating canonical Wnt-regulated
stemness, proliferation and terminal differentiation of hepatic
progenitors. Oncotarget. 8:27105–27119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang L, Cheng H, Yue Y, Li S, Zhang D and
He R: H19 knockdown suppresses proliferation and induces apoptosis
by regulating miR-148b/WNT/β-catenin in ox-LDL-stimulated vascular
smooth muscle cells. J Biomed Sci. 25:112018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zimmerman M, Hu X and Liu K: Experimental
metastasis and CTL adoptive transfer immunotherapy mouse model. J
Vis Exp. 45:20772010.
|
|
21
|
Yang J, Cong X, Ren M, Sun H, Liu T, Chen
G, Wang Q, Li Z, Yu S and Yang Q: Circular RNA hsa_circRNA_0007334
is predicted to promote MMP7 and COL1A1 expression by functioning
as a miRNA sponge in pancreatic ductal adenocarcinoma. J Oncol.
2019:76308942019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang W, Shen C, Li C, Yang G, Liu H, Chen
X, Zhu D, Zou H, Zhen Y, Zhang D, et al: miR-577 inhibits
glioblastoma tumor growth via the Wnt signaling pathway. Mol
Carcinog. 55:575–585. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grant TJ, Hua K and Singh A: Molecular
pathogenesis of pancreatic cancer. Prog Mol Biol Transl Sci.
144:241–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masiak-Segit W, Rawicz-Pruszyński K,
Skórzewska M and Polkowski WP: Surgical treatment of pancreatic
cancer. Pol Przegl Chir. 90:45–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YT, Tan YJ and Oon CE: Molecular
targeted therapy: Treating cancer with specificity. Eur J
Pharmacol. 834:188–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duguang L, Jin H, Xiaowei Q, Peng X,
Xiaodong W, Zhennan L, Jianjun Q and Jie Y: The involvement of
lncRNAs in the development and progression of pancreatic cancer.
Cancer Biol Ther. 18:927–936. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Yang X, Kang X and Liu S: The
regulatory roles of long noncoding RNAs in the biological behavior
of pancreatic cancer. Saudi J Gastroenterol. 25:145–151. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng SJ, Chen HY, Ye Z, Deng SC, Zhu S,
Zeng Z, He C, Liu ML, Huang K, Zhong JX, et al: Hypoxia-induced
LncRNA-BX111 promotes metastasis and progression of pancreatic
cancer through regulating ZEB1 transcription. Oncogene.
37:5811–5828. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y, Zhao
X, Li W, Zheng S, Ye H, Wang L, et al: LncRNA HOTTIP modulates
cancer stem cell properties in human pancreatic cancer by
regulating HOXA9. Cancer Lett. 410:68–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou L, Liang X, Zhang L, Yang L, Nagao N,
Wu H, Liu C, Lin S, Cai G and Liu J: MiR-27a-3p functions as an
oncogene in gastric cancer by targeting BTG2. Oncotarget.
7:51943–51954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Lu Z, Wang N, Feng J, Zhang J,
Luan L, Zhao W and Zeng X: Long noncoding RNA DANCR promotes
colorectal cancer proliferation and metastasis via miR-577
sponging. Exp Mol Med. 50:1–17. 2018. View Article : Google Scholar
|
|
34
|
Du C, Wang HX, Chen P and Chen CH:
STAT3-induced upregulation of lncRNA DUXAP8 functions as ceRNA for
miR-577 to promote the migration and invasion in colorectal cancer
through the regulation of RAB14. Eur Rev Med Pharmacol Sci.
23:6105–6118. 2019.PubMed/NCBI
|
|
35
|
Yin C, Mou Q, Pan X, Zhang G, Li H and Sun
Y: MiR-577 suppresses epithelial-mesenchymal transition and
metastasis of breast cancer by targeting Rab25. Thorac Cancer.
9:472–479. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang LY, Li B, Jiang HH, Zhuang LW and Liu
Y: Inhibition effect of miR-577 on hepatocellular carcinoma cell
growth via targeting β-catenin. Asian Pac J Trop Med. 8:923–929.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang Z, Jiang C and Fang J: Up-regulated
lnc-SNHG1 contributes to osteosarcoma progression through
sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin
pathway. Biochem Biophys Res Commun. 495:238–245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Modi S, Kir D, Banerjee S and Saluja A:
Control of apoptosis in treatment and biology of pancreatic cancer.
J Cell Biochem. 117:279–288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu F, Xia Z, Zhang M, Ding J, Feng Y, Wu
J, Dong Y, Gao W, Han Z, Liu Y, et al: SMARCAD1 promotes pancreatic
cancer cell growth and metastasis through Wnt/β-catenin-mediated
EMT. Int J Biol Sci. 15:636–646. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nagano H, Tomimaru Y, Eguchi H, Hama N,
Wada H, Kawamoto K, Kobayashi S, Mori M and Doki Y: MicroRNA-29a
induces resistance to gemcitabine through the Wnt/β-catenin
signaling pathway in pancreatic cancer cells. Int J Oncol.
43:1066–1072. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhan T, Chen X, Tian X, Han Z, Liu M, Zou
Y, Huang S, Chen A, Cheng X, Deng J, et al: MiR-331-3p links to
drug resistance of pancreatic cancer cells by activating
WNT/β-catenin signal via ST7L. Technol Cancer Res Treat.
19:15330338209458012020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X,
Zhang X, Huang Y, Zhang R, Wei J, et al: LncRNA PVT1 promotes
gemcitabine resistance of pancreatic cancer via activating
Wnt/β-catenin and autophagy pathway through modulating the
miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 19:1182020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fan Y, Li H, Yu Z, Dong W, Cui X, Ma J and
Li S: Long non-coding RNA FGD5-AS1 promotes non-small cell lung
cancer cell proliferation through sponging hsa-miR-107 to
up-regulate FGFRL1. Biosci Rep. 40:BSR201933092020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu L, Zhan Y, Huang Y and Huang L: LncRNA
FGD5-AS1 can be predicted as therapeutic target in oral cancer. J
Oral Pathol Med. 49:243–252. 2020. View Article : Google Scholar : PubMed/NCBI
|
